https://idataresearch.com/wp-content/uploads/2016/04/ReportIcon-Vascular-MC.jpg

Peripherally Inserted Central Catheters Market Analysis | India | 2017-2023 | MedCore

  • Year: 2017
  • Scope: 2013-2023
  • Region: India
  • Pages: 376
  • Published Date: 1/1/2017
  • Type: MedCore

Growth in the unit sales of advanced materials PICCs is expected to drive gains in the share of power-injectable PICCs over the forecast period.

Although power-injectable PICCs have become the standard of care in some countries such as the United States, India still prefers conventional PICCs and is over ten years behind most developed countries.

Segments Covered in This Market

  • Conventional PICC Market
  • Power-Injectable PICC Market

Report Data Types Included

  • Unit Sales, Average Selling Prices, Market Value & Growth Trends
  • 10 Year Scope (3 Year Historical + 7 Year Forecast Period)
  • Market Drivers & Limiters for Each Segment
  • Competitive Analysis with Market Shares
  • Product Portfolios
  • Related Press Releases from Top Competitors

Companies Analyzed

Of the many companies in the Peripherally Inserted Central Catheter market, C. R. Bard was the leader, followed by Vygon and Teleflex Medical. Bard has been active in growing the PICC market globally by offering educational services to spread awareness about PICCs. Other notable competitors in this market segment include B. Braun and Cook Medical.

About Our In-Depth MedCore Research

Our analysts meticulously research for up to 3 to 4 months to put together one suite of reports (MedSuite), which is a comprehensive analysis on a group of healthcare markets. A MedCore is one portion of that analysis that focuses on one market segment, and provides further detailed segmentation to get a much more granular set of market data.

This MedCore is also found in the full report suite titled India Market Report Suite for Vascular Access Devices and Accessories – MedSuite

Learn More about these product types

TABLE OF CONTENTS I
LIST OF FIGURES XVI
LIST OF CHARTS XX
EXECUTIVE SUMMARY 1
INDIA VASCULAR ACCESS DEVICE AND ACCESSORIES MARKET OVERVIEW 1
COMPETITIVE ANALYSIS 4
MARKET TRENDS 6
MARKET DEVELOPMENTS 7
MARKETS INCLUDED 8
KEY REPORT UPDATES 9
VERSION HISTORY 9
RESEARCH METHODOLOGY 10
1.1 RESEARCH SCOPE 10
1.2 IDATA’S 9-STEP METHODOLOGY 10
Step 1: Project Initiation & Team Selection 10
Step 2: Prepare Data Systems and Perform Secondary Research 12
Step 3: Preparation for Interviews & Questionnaire Design 13
Step 4: Performing Primary Research 14
Step 5: Research Analysis: Establishing Baseline Estimates 16
Step 6: Market Forecast and Analysis 17
Step 7: Identify Strategic Opportunities 19
Step 8: Final Review and Market Release 20
Step 9: Customer Feedback and Market Monitoring 21
DISEASE OVERVIEW 22
2.1 BASIC ANATOMY 22
2.1.1 Human Vascular System 22
2.2 VASCULAR PATHOLOGY AND DISORDERS 23
2.2.1 Cancer 23
2.2.2 End-Stage Renal Disease 24
2.2.3 Diabetes 26
PRODUCT ASSESSMENT 29
3.1 PRODUCT PORTFOLIOS 29
3.1.1 Peripherally Inserted Central Catheters 29
3.1.1.1 Introduction 29
3.1.1.1.1 PICC Placement 29
3.1.1.2 AngioDynamics 31
3.1.1.2.1 BioFlo® 31
3.1.1.3 Argon Medical 31
3.1.1.3.1 First PICC™ 31
3.1.1.3.2 L-Cath™ 31
3.1.1.4 B. Braun 31
3.1.1.4.1 V-5™ 31
3.1.1.4.2 Other PICC Offerings 31
3.1.1.5 Cook Medical 31
3.1.1.5.1 Spectrum® 31
3.1.1.5.2 Other PICC Offerings 32
3.1.1.6 C.R. Bard 32
3.1.1.6.1 PowerPICC® 32
3.1.1.6.2 Groshong® 32
3.1.1.6.3 Per-Q-Cath® 32
3.1.1.6.4 Other PICC Offerings 32
3.1.1.7 GaltNeedleTech 32
3.1.1.7.1 SYNERGY™ 32
3.1.1.8 Medcomp 33
3.1.1.8.1 Pro-PICC™ 33
3.1.1.8.2 Vascu-PICC™ 33
3.1.1.9 Neo Medical 33
3.1.1.9.1 Neo-Magic™ 33
3.1.1.9.2 V-Cath™ 33
3.1.1.10 PFM Medical 33
3.1.1.10.1 pfm CT PICC II 33
3.1.1.11 Teleflex Medical 33
3.1.1.11.1 ARROW® 33
3.1.1.12 Trinity Sterile 34
3.1.1.12.1 Trinity™ PICC II 34
3.1.1.13 Vygon 34
3.1.1.13.1 Premicath™ 34
3.1.1.13.2 Epicutaneo-Cava™ 34
3.1.1.13.3 Nutriline™ 34
3.1.1.13.4 Lifecath™ 34
3.2 REGULATORY ISSUES AND RECALLS 35
3.2.1 November 2015 35
3.2.2 October 2015 35
3.2.3 September 2015 36
3.2.4 August 2015 38
3.2.5 July 2015 39
3.2.6 April 2015 41
3.2.7 March 2015 42
3.2.8 February 2015 43
3.2.9 January 2015 43
3.2.10 December 2014 44
3.2.11 October 2014 45
3.2.12 September 2014 46
3.2.13 May 2014 47
3.2.14 April 2014 47
3.2.15 March 2014 48
3.2.16 January 2014 48
3.2.17 December 2013 49
3.2.18 September 2013 50
3.2.19 August 2013 51
3.2.20 June 2013 51
3.2.21 March 2013 52
3.2.22 February 2013 53
3.2.23 December 2012 53
3.2.24 August 2012 53
3.2.25 June 2012 54
3.2.26 May 2012 55
3.2.27 March 2012 56
3.2.28 February 2012 57
3.2.29 January 2012 57
3.3 CLINICAL TRIALS 61
3.3.1 Peripherally Inserted Central Catheters 62
3.4 PRODUCT PIPELINES 72
3.4.1 Alliance Vascular Devices, LLC 72
3.4.1.1 FreeHand Safety Huber Needle® 72
3.4.2 AngioDynamics 72
3.4.2.1 Celerity™ PICC Tip Confirmation System with Navigation 72
3.4.2.2 Firefly 72
3.4.2.3 BioFlo® PICC Line Extension 73
3.4.2.4 BioFlo® Port Line Extension 73
3.4.2.5 Next Generation BioFlo® PICC 73
3.4.2.6 Next Generation BioFlo® Port 73
3.4.3 Bluegrass Vascular Technologies, Inc. 73
3.4.3.1 Surfacer® Inside-Out™ Access System 73
3.4.4 C.R. Bard 73
3.4.4.1 Chemical-Resistant PICCs 73
3.4.4.2 Novel Advanced Material PICCs 74
3.4.4.3 PowerGlide® Pro Midline 74
3.4.4.4 AccuCath® 74
3.4.4.5 Xenesis™ Acute Hemodialysis Catheter 74
3.4.4.6 Site~Rite® 8 Ultrasound System 74
3.4.5 M. C. Johnson 74
3.4.5.1 PICC Securement Device 74
3.4.6 Nipro Medical 75
3.4.6.1 Shielding Safety Needle 75
3.4.6.2 Safety Syringe 75
3.4.6.3 Safety PIVC 75
3.4.7 Parasol Medical 75
3.4.7.1 Catheter Securement Device 75
3.4.8 PAVmed Inc. 75
3.4.8.1 NextCath™ 75
3.4.9 Phase One Medical 75
3.4.9.1 Goldilocks™ Long Term Hemodialysis Catheter 75
3.4.9.2 Triple-Lumen Symetrex™ Hemodialysis Catheter 76
3.4.10 Prodigy Diabetes Care, LLC. 76
3.4.10.1 Insulin Pen Needles 76
3.4.11 Sharklet Technologies, Inc. 76
3.4.11.1 Sharklet™ Central Venous Catheter 76
3.4.12 Starboard Medical 76
3.4.12.1 Catheter Securement Devices 76
3.4.13 Teleflex Medical 77
3.4.13.1 Arrow® Endurance™ Extended Dwell Peripheral Catheter System 77
3.4.13.2 Tip Confirmation for CVCs, Chronic Hemodialysis Catheters & Ports 77
3.4.14 Vascular Access Technologies, Inc. 77
3.4.14.1 SAFECVAD™ 77
PERIPHERALLY INSERTED CENTRAL CATHETER MARKET 78
4.1 MARKET OVERVIEW 78
4.2 MARKET ANALYSIS AND FORECAST 82
4.2.1 Total Peripherally Inserted Central Catheter Market 82
4.2.2 Conventional Peripherally Inserted Central Catheter Market 84
4.2.3 Power-Injectable Peripherally Inserted Central Catheter Market 86
4.3 DRIVERS AND LIMITERS 88
4.3.1 Market Drivers 88
4.3.2 Market Limiters 89
4.4 COMPETITIVE MARKET SHARE ANALYSIS 91
ABBREVIATIONS 94
APPENDIX: COMPANY PRESS RELEASES 95
The "India Market Report Suite for Vascular Access Devices and Accessories 2017 - MedSuite" includes analysis on the following companies currently active in this market:
Teleflex Medical
Poly Medicure
B. Braun
Becton Dickinson
C. R. Bard
Covidien
Smiths Medical
Others include: Cardinal Health, Cook Medical, GE Healthcare, Manohar International, Medcomp, Medikit, Covidien, Nipro Medical, PFM Medical, Poly Medicure Limited, Terumo, Toshiba, Vygon, etc.
*Not all companies are currently active in every segment or sub-report from this suite. For more details contact an iData Research Product Advisor.
Chart 1 1: Vascular Access Device and Accessories Market by Segment, India, 2013 – 2023 2
Chart 1 2: Vascular Access Device and Accessories Market by Segment, India, 2016 & 2023 3
Chart 4 1: Peripherally Inserted Central Catheter Market by Segment, India, 2013 – 2023 80
Chart 4 2: Peripherally Inserted Central Catheter Market Breakdown, India, 2016 81
Chart 4 3: Peripherally Inserted Central Catheter Market Breakdown, India, 2023 81
Chart 4 4: Total Peripherally Inserted Central Catheter Market, India, 2013 – 2023 83
Chart 4 5: Conventional Peripherally Inserted Central Catheter Market, India, 2013 – 2023 85
Chart 4 6: Power-Injectable Peripherally Inserted Central Catheter Market, India, 2013 – 2023 87
Chart 4 7: Leading Competitors, Peripherally Inserted Central Catheter Market, India, 2016 93

Figure 1 1: Vascular Access Device and Accessories Market by Segment India, 2016 (1 of 2) 4
Figure 1 2: Vascular Access Device and Accessories Market by Segment India, 2016 (2 of 2) 4
Figure 1 3: Companies Researched in this Report, India, 2016 5
Figure 1 4: Factors Impacting the Vascular Access Device and Accessories Market by Segment, India 6
Figure 1 5: Recent Events in the Vascular Access Device and Accessories MarketIndia, 2012 – 2016 7
Figure 1 6: Vascular Access Device and Accessories Markets Covered, India, 2016 8
Figure 1 7: Key Report Updates 9
Figure 1 8: Version History 9
Figure 3 1: Class 2 Device Recall Medtronic 35
Figure 3 2: Class 2 Device Recall Smiths Medical 35
Figure 3 3: Class 2 Device Recall Arrow 36
Figure 3 4: Class 2 Device Recall Arrow 36
Figure 3 5: Class 2 Device Recall Covidien (Medtronic) 37
Figure 3 6: Class 2 Device Recall Arrow 38
Figure 3 7: Class 2 Device Recall Medline 38
Figure 3 8: Class 2 Device Recall Arrow 38
Figure 3 9: Class 2 Device Recall B. Braun 38
Figure 3 10: Class 3 Device Recall Bard Access 39
Figure 3 11: Class 2 Device Recall Covidien (Medtronic) 39
Figure 3 12: Class 2 Device Recall Bard Access 41
Figure 3 13: Class 2 Device Recall Bard Access 41
Figure 3 14: Class 2 Device Recall Medcomp & AngioDynamics 42
Figure 3 15: Class 2 Device Recall Bard Access 42
Figure 3 16: Class 2 Device Recall Arrow 43
Figure 3 17: Class 2 Device Recall Medcomp 43
Figure 3 18: Class 2 Device Recall Arrow 43
Figure 3 19: Class 2 Device Recall Arrow 44
Figure 3 20: Class 2 Device Recall Smiths Medical 44
Figure 3 21: Class 2 Device Recall PFM Medical 44
Figure 3 22: Class 2 Device Recall PFM Medical 44
Figure 3 23: Class 2 Device Recall Becton Dickinson 45
Figure 3 24: Class 2 Device Recall Arrow 45
Figure 3 25: Class 2 Device Recall Arrow 45
Figure 3 26: Class 2 Device Recall Navilyst Medical 45
Figure 3 27: Class 2 Device Recall Argon Medical 46
Figure 3 28: Class 2 Device Recall Arrow 47
Figure 3 29: Class 2 Device Recall Arrow 47
Figure 3 30: Class 2 Device Recall Arrow 48
Figure 3 31: Class 2 Device Recall Bard Access 48
Figure 3 32: Class 2 Device Recall Navilyst Medical 48
Figure 3 33: Class 2 Device Recall Bard Access 49
Figure 3 34: Class 2 Device Recall Smiths Medical 49
Figure 3 35: Class 2 Device Recall B. Braun 49
Figure 3 36: Class 2 Device Recall Smiths Medical 50
Figure 3 37: Class 2 Device Recall Access Scientific 50
Figure 3 38: Class 2 Device Recall Covidien (Medtronic) 50
Figure 3 39: Class 2 Device Recall Arrow 51
Figure 3 40: Class 2 Device Recall Bard Access 51
Figure 3 41: Class 2 Device Recall Becton Dickinson 51
Figure 3 42: Class 2 Device Recall Churchill Medical Systems, Inc. A Vygon Company 52
Figure 3 43: Class 2 Device Recall Bard Access 52
Figure 3 44: Class 2 Device Recall Churchill Medical Systems, Inc. A Vygon Company 52
Figure 3 45: Class 2 Device Recall Medcomp 53
Figure 3 46: Class 2 Device Recall Becton Dickinson 53
Figure 3 47: Class 3 Device Recall Bard Access 53
Figure 3 48: Class 2 Device Recall Medcomp 54
Figure 3 49: Class 1 Device Recall Arrow 54
Figure 3 50: Class 2 Device Recall Arrow 54
Figure 3 51: Class 2 Device Recall Vygon 54
Figure 3 52: Class 2 Device Recall Covidien (Medtronic) 55
Figure 3 53: Class 2 Device Recall Medcomp 56
Figure 3 54: Class 2 Device Recall Churchill Medical Systems, Inc. A Vygon Company 56
Figure 3 55: Class 2 Device Recall Christie Medical Holdings 56
Figure 3 56: Class 3 Recall Bard Access 56
Figure 3 57: Class 2 Device Recall AngioDynamics 57
Figure 3 58: Class 2 Device Recall Becton Dickinson 57
Figure 3 59: Class 2 Device Recall AngioDynamics 57
Figure 3 60: Class 2 Device Recall AngioDynamics 59
Figure 3 61: Class 3 Device Recall AngioDynamics 60
Figure 3 62: Class 2 Device Recall AngioDynamics 60
Figure 3 63: A Pragmatic Randomized Trial Standard of Care Vascular Access Strategies 62
Figure 3 64: PICC and Midline Related Complications: A Multicenter Observational Study 63
Figure 3 65: Complications Associated With Central Venous Access 63
Figure 3 66: Evaluation of Electrocardiographic Guidance 63
Figure 3 67: Phase II Randomised Study Comparing the Tolerance of PICC Line 64
Figure 3 68: Randomized, Prospective, Single-center Study 64
Figure 3 69: A Randomized Controlled Trial Comparing Ultrasound Guided PICC Line Insertion 65
Figure 3 70: Ultrasound-guided Peripheral Vascular Access 65
Figure 3 71: Vascular Access in Cancer Patients 66
Figure 3 72: A Monocenter Prospective Study 67
Figure 3 73: Vascular Access in Hematological Patients 67
Figure 3 74: ECG Versus Ultrasound-guided Positioning of the Peripherally Inserted Central Catheter (PICC) Tip 67
Figure 3 75: Sequential Pneumatic Compression 68
Figure 3 76: Reliability of Central Venous Pressure Measurements 68
Figure 3 77: Time and Motion Related to PICC Insertion Process and Catheter Tip Confirmation 69
Figure 3 78: A Randomized Open-labeled Multicenter Study 69
Figure 3 79: A Phase III Study of Peripherally Inserted Versus Centrally Inserted Central Venous Catheters 70
Figure 3 80: A Randomized Prospective Multicenter Evaluation 70
Figure 3 81: Randomized Double Blind Comparison 71
Figure 3 82: An Observational, Prospective, Single-center Study of Placement and Confirmation 71
Figure 4 1: Peripherally Inserted Central Catheter Market by Segment, India, 2013 – 2023 (IN?M) 79
Figure 4 2: Peripherally Inserted Central Catheter Market by Segment, India, 2013 – 2023 (IN?M) 79
Figure 4 3: Total Peripherally Inserted Central Catheter Market, India, 2013 – 2023 82
Figure 4 4: Conventional Peripherally Inserted Central Catheter Market, India, 2013 – 2023 84
Figure 4 5: Power-Injectable Peripherally Inserted Central Catheter Market, India, 2013 – 2023 86
Figure 4 6: Drivers and Limiters, Peripherally Inserted Central Catheter Market, India, 2016 90
Figure 4 7: Leading Competitors, Peripherally Inserted Central Catheter Market, India, 2016 92
Figure 6 1: Press Release Summary 95

iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology